datalabs-logo

  • Ask Datalabs
  • My Feed
  • Companies
  • Investors
  • People
  • Funding Rounds
  • Acquisitions

  • Research Reports
  • Industries
  • Locations
Welcome Cure-logo
Welcome Cure
Welcome Cure-logoWelcome Cure-logo
Welcome Cure

Welcome Cure - Financials, Revenue, P&L Statement, Balance Sheet, Cash Flow & More

Private
WELCOME CURE PRIVATE LIMITED
Private
WELCOME CURE PRIVATE LIMITED
2014
2014

Founded in 2014, Welcome Cure operates in Health Tech industry. Initially focused on delivering homeopathic consultations and treatment plans online, the company has grown to incorporate comprehensive...

Funding stage:

Seed

Last funding:

18/10/2023

Total funding:

$6.48 Mn+

Revenue:

₹4.4 Cr+ (FY25)
Prev. FY

Investors

Employee count:

40

Last 90d

40

Last 90d

Web traffic:

27K

27K

Last 30d

Last 30d

Glassdoor Rating:

Welcome Cure: Financial Breakdown

Decoding financial health metrics of Welcome Cure

  • total_revenue_logo
    Total Revenue
    ₹4.4 Cr
    120%

    Prev. FY

  • total_expenses_logo
    Total Expenses
    ₹1.9 Cr
    -52%

    Prev. FY

  • profit_after_tax_logo
    Profit After Tax
    ₹2.6 Cr
    261%

    Prev. FY

  • total_assets_logo
    Total Assets
    ₹4.4 Cr
    -13%

    Prev. FY

  • net_profit_margin_logo
    Net Profit Margin
    57.7%
    172%

    Prev. FY

Note: Above mentioned stats are for FY24-25

FAQs on Financials of Welcome Cure

Yes. In FY25, Welcome Cure reported a profit after tax of ₹2.6 Cr, making it profitable.

Welcome Cure's revenue grew 120.8% year-on-year, from ₹2.0 Cr in FY24 to ₹4.4 Cr in FY25.

Welcome Cure's estimated EBITDA for FY25 was ₹3.1 Cr, derived from its profit before tax, finance costs, and depreciation & amortisation.

In FY25, Welcome Cure posted revenue of ₹4.4 Cr (up 120.8% YoY) and a profit after tax of ₹2.6 Cr. Explore the full financials of Welcome Cure here...

Disclaimer

Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.

Quick Links

MY FEEDDISCOVERRESEARCH